Developer docs
API playgroundTry for free, no card

Search company profiles

Catenion

Full company profile

uuid0029cjq

Namestring
Catenion
Legal namestring
Catenion GmbH
Websiteurl
catenion.com
Company typeenum
Private
Founded yearint
2003
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biopharma consulting, R&D strategy advisory, pharmaceutical portfolio management, biotech due diligence, drug target prioritization
NAICS code4 codes
  • Management, Scientific, and Technical Consulting Services5416
  • Management Consulting Services54161
  • Other Management Consulting Services541618
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Commercial Physical & Biological Research8731
Product category
Biopharmaceutical Management Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Management Consulting Services
TypeProfessional Services
Description

Catenion generates revenue through bespoke consulting engagements with pharmaceutical, biotech, and medical device companies. Engagements cover corporate and R&D strategy, asset/company screening, portfolio review, target prioritization, therapeutic area strategy, clinical development strategy, science and technology mapping, R&D risk assessment, and due diligence. Revenue is project-based and typically involves multi-month engagements with senior executives.

catenion.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Catenion is a science-driven management consulting firm that delivers bespoke strategic advisory services to pharmaceutical, biotechnology, medical device, government, and academic clients. Its offerings span corporate and R&D strategy, asset and company screening, portfolio review and optimization, target selection and prioritization, therapeutic area strategy and disease mapping, clinical development strategy, R&D risk assessment, science and technology mapping, due diligence, and market research, all supported by an in-house Data Science Unit and proprietary analytical tools.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 1,500+ R&D projects assessed using proprietary tools across the biopharmaceutical industry
+2 more records
Product overview1 text field

Catenion is a management consulting firm focused on science-driven strategy for the pharmaceutical and biotech industry. The company offers a comprehensive suite of consulting services organized around R&D strategy and corporate advisory, including Corporate and R&D Strategy, Asset & Company Screening (via the proprietary ASAP methodology), Portfolio Review & Optimization, Target Selection & Prioritization, Therapeutic Area Strategy & Disease Mapping, Clinical Development Strategy, R&D Risk Assessment (using a proprietary tool with 500+ criteria), Due Diligence, Science & Technology Mapping, Market Research, and Catenion Academy training programs. These services are powered by a dedicated Data Science Unit comprising bioinformaticians, computational biologists, and data engineers who develop and apply machine learning and state-of-the-art computational techniques, integrating genomic, proteomic, clinical, competitive, and market data into proprietary knowledge graphs to support all consulting engagements.

Product and service12 records
1Corporate and R&D Strategy
CategoryConsulting Service
2ASAP (Accelerated Search & Acquisition Process)
CategoryProprietary Methodology
3Portfolio Review & Optimization
CategoryConsulting Service
4Target Selection & Prioritization
CategoryConsulting Service
5Therapeutic Area Strategy & Disease Mapping
CategoryConsulting Service
6Indication Evaluation & Therapeutic Expansion
CategoryConsulting Service
7Clinical Development Strategy
CategoryConsulting Service
8R&D Risk Assessment
CategoryConsulting Service
9Due Diligence
CategoryConsulting Service
10Science & Technology Mapping
CategoryConsulting Service
11Market Research
CategoryConsulting Service
12Catenion Academy
CategoryTraining Program
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CRA's Life Sciences practice provides strategy and due diligence consulting to pharma and biotech on R&D portfolio optimization, asset valuation, and commercial strategy. Direct overlap with Catenion's portfolio review, ASAP-style asset screening, and due diligence offerings for investors and corporate clients.

TypeBroad incumbent
Description

BCG's Healthcare practice advises Big Pharma and biotech on R&D transformation, launch, and portfolio strategy. Comparable at the strategic mandate level but at global incumbent scale; BCG often competes with Catenion on top-priority pharma strategy engagements.

TypeDirect peer
Description

Putnam is a boutique life sciences strategy consultancy focused on biopharma commercial and pipeline strategy. Like Catenion, it serves a Big Pharma client base with science-driven engagements, though it leans more heavily into commercial and market access rather than early-stage R&D.

TypeDirect peer
Description

LEK is a global strategy consulting firm with a dedicated Life Sciences practice advising pharma, biotech, and medtech clients on R&D, commercial strategy, and M&A. Like Catenion, it serves senior biopharma executives with bespoke strategic engagements, but operates at materially larger scale and broader service breadth.

5ZS Associates
TypeDirect peer
Description

ZS is a large consulting firm focused on pharma and biotech commercial and R&D strategy, with deep data and analytics capabilities. Comparable to Catenion in serving senior biopharma decision-makers, but at substantially greater scale and with broader technology/data product offerings.

TypeDirect peer
Description

Lumanity is a biopharma-focused consulting and commercialization firm offering strategic advisory, evidence, and access services to pharma and biotech. Comparable peer for life sciences strategy engagements, particularly in portfolio/asset strategy and commercial due diligence.

7Defined Health / Cello Health (now part of PharmaLex)
TypeEmerging player
Description

Defined Health was a boutique biopharma strategy consultancy providing therapeutic area strategy and asset diligence to biotech and pharma. Closely aligned with Catenion's boutique model and target customer profile, though smaller and more US-centric in its historical footprint.

TypeBroad incumbent
Description

Bain's Healthcare practice delivers R&D, commercial, and M&A advisory to biopharma clients. Overlaps with Catenion in serving senior pharma executives on portfolio and asset strategy, but with broader industry coverage and significantly larger engagement teams.

TypeBroad incumbent
Description

McKinsey's Pharma & Medical Products practice advises the largest global biopharma companies on R&D productivity, portfolio strategy, and M&A. Catenion competes for the same board-level strategic mandates, but McKinsey brings multi-thousand-consultant scale and broader functional coverage, while Catenion competes on science depth and PhD-led analysis.

10Trinity Partners
TypeDirect peer
Description

Trinity is a life sciences-focused consulting firm advising biopharma on commercial strategy, market access, and portfolio decisions. Direct peer in serving mid-to-large biopharma with strategic engagements, though with greater emphasis on commercial and pricing analytics than Catenion's R&D-focused methodology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers20 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Catenion

Biopharmaceutical Management Consultingcatenion.com

Catenion firmographics

Firmographics
Name
Catenion
Legal name
Catenion GmbH
Website
https://catenion.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where Catenion is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices5 records

Markets served

Catenion business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Management Consulting Services: Catenion generates revenue through bespoke consulting engagements with pharmaceutical, biotech, and medical device companies. Engagements cover corporate and R&D strategy, asset/company screening, portfolio review, target prioritization, therapeutic area strategy, clinical development strategy, science and technology mapping, R&D risk assessment, and due diligence. Revenue is project-based and typically involves multi-month engagements with senior executives.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Catenion product offering

Product offering

Core offering

Catenion is a science-driven management consulting firm that delivers bespoke strategic advisory services to pharmaceutical, biotechnology, medical device, government, and academic clients. Its offerings span corporate and R&D strategy, asset and company screening, portfolio review and optimization, target selection and prioritization, therapeutic area strategy and disease mapping, clinical development strategy, R&D risk assessment, science and technology mapping, due diligence, and market research, all supported by an in-house Data Science Unit and proprietary analytical tools.

Product overview

Catenion is a management consulting firm focused on science-driven strategy for the pharmaceutical and biotech industry. The company offers a comprehensive suite of consulting services organized around R&D strategy and corporate advisory, including Corporate and R&D Strategy, Asset & Company Screening (via the proprietary ASAP methodology), Portfolio Review & Optimization, Target Selection & Prioritization, Therapeutic Area Strategy & Disease Mapping, Clinical Development Strategy, R&D Risk Assessment (using a proprietary tool with 500+ criteria), Due Diligence, Science & Technology Mapping, Market Research, and Catenion Academy training programs. These services are powered by a dedicated Data Science Unit comprising bioinformaticians, computational biologists, and data engineers who develop and apply machine learning and state-of-the-art computational techniques, integrating genomic, proteomic, clinical, competitive, and market data into proprietary knowledge graphs to support all consulting engagements.

Differentiator

Problem solved

Functional benefit

Products and services

  • Corporate and R&D Strategy
  • ASAP (Accelerated Search & Acquisition Process)
  • Portfolio Review & Optimization
  • Target Selection & Prioritization
  • Therapeutic Area Strategy & Disease Mapping
  • Indication Evaluation & Therapeutic Expansion
  • Clinical Development Strategy
  • R&D Risk Assessment
  • Due Diligence
  • Science & Technology Mapping
  • Market Research
  • Catenion Academy

Quantifiable outcome

  • 1,500+ R&D projects assessed using proprietary tools across the biopharmaceutical industry
  • +2 more outcomes

Companies that use Catenion

Customer profile

Named customers20 records

Segments4 records

Ideal customer profiles4 records

Catenion technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Catenion partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Catenion competitors and assessment

Company assessment

Direct peers

  • Charles River Associates (CRA): CRA's Life Sciences practice provides strategy and due diligence consulting to pharma and biotech on R&D portfolio optimization, asset valuation, and commercial strategy. Direct overlap with Catenion's portfolio review, ASAP-style asset screening, and due diligence offerings for investors and corporate clients.
  • Putnam Associates: Putnam is a boutique life sciences strategy consultancy focused on biopharma commercial and pipeline strategy. Like Catenion, it serves a Big Pharma client base with science-driven engagements, though it leans more heavily into commercial and market access rather than early-stage R&D.
  • LEK Consulting: LEK is a global strategy consulting firm with a dedicated Life Sciences practice advising pharma, biotech, and medtech clients on R&D, commercial strategy, and M&A. Like Catenion, it serves senior biopharma executives with bespoke strategic engagements, but operates at materially larger scale and broader service breadth.
  • ZS Associates: ZS is a large consulting firm focused on pharma and biotech commercial and R&D strategy, with deep data and analytics capabilities. Comparable to Catenion in serving senior biopharma decision-makers, but at substantially greater scale and with broader technology/data product offerings.
  • Lumanity: Lumanity is a biopharma-focused consulting and commercialization firm offering strategic advisory, evidence, and access services to pharma and biotech. Comparable peer for life sciences strategy engagements, particularly in portfolio/asset strategy and commercial due diligence.
  • Trinity Partners: Trinity is a life sciences-focused consulting firm advising biopharma on commercial strategy, market access, and portfolio decisions. Direct peer in serving mid-to-large biopharma with strategic engagements, though with greater emphasis on commercial and pricing analytics than Catenion's R&D-focused methodology.

Broad incumbents

  • Boston Consulting Group (Healthcare): BCG's Healthcare practice advises Big Pharma and biotech on R&D transformation, launch, and portfolio strategy. Comparable at the strategic mandate level but at global incumbent scale; BCG often competes with Catenion on top-priority pharma strategy engagements.
  • Bain & Company (Healthcare): Bain's Healthcare practice delivers R&D, commercial, and M&A advisory to biopharma clients. Overlaps with Catenion in serving senior pharma executives on portfolio and asset strategy, but with broader industry coverage and significantly larger engagement teams.
  • McKinsey & Company (Pharma & Medical Products): McKinsey's Pharma & Medical Products practice advises the largest global biopharma companies on R&D productivity, portfolio strategy, and M&A. Catenion competes for the same board-level strategic mandates, but McKinsey brings multi-thousand-consultant scale and broader functional coverage, while Catenion competes on science depth and PhD-led analysis.

Emerging players

  • Defined Health / Cello Health (now part of PharmaLex): Defined Health was a boutique biopharma strategy consultancy providing therapeutic area strategy and asset diligence to biotech and pharma. Closely aligned with Catenion's boutique model and target customer profile, though smaller and more US-centric in its historical footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Catenion social profiles

Digital presence

Catenion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Catenion leadership team

Management profile

Number of profiles

Profiles9 records

Catenion funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Catenion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Catenion

What does Catenion do?

Catenion is a science-driven management consulting firm that delivers bespoke strategic advisory services to pharmaceutical, biotechnology, medical device, government, and academic clients. Its offerings span corporate and R&D strategy, asset and company screening, portfolio review and optimization, target selection and prioritization, therapeutic area strategy and disease mapping, clinical development strategy, R&D risk assessment, science and technology mapping, due diligence, and market research, all supported by an in-house Data Science Unit and proprietary analytical tools.

Is Catenion a public or private company?

Catenion is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Catenion founded?

Catenion was founded in 2003. It employs 11 to 50 people.

Where is Catenion based?

Catenion is headquartered in Berlin, Germany, in the Europe region.

How does Catenion make money?

One revenue line is on record: management Consulting Services.

Who are Catenion's main competitors?

Direct peers on record are Charles River Associates (CRA), Putnam Associates, LEK Consulting, ZS Associates, Lumanity and Trinity Partners. Broad incumbents are Boston Consulting Group (Healthcare), Bain & Company (Healthcare) and McKinsey & Company (Pharma & Medical Products). Defined Health / Cello Health (now part of PharmaLex) is listed as an emerging player.

Does Catenion have an API?

No public API is recorded for Catenion.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals